110 related articles for article (PubMed ID: 19378767)
1. [Development of treatment adherence by jellification of itraconazole oral solution].
Wada H; Tanabe S; Ichikawa K; Sano F; Kubo Y; Matsuhashi Y; Nakanishi H; Tasaka T; Sugihara T
Jpn J Antibiot; 2009 Feb; 62(1):17-25. PubMed ID: 19378767
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
3. [Improvement of patient adherence by mixing oral itraconazole solution with a beverage (orange juice)].
Adachi Y; Sumikuma T; Kagami R; Nishio A; Akasaka K; Tsunemine H; Kodaka T; Hiramatsu Y; Tada H
Rinsho Ketsueki; 2010 May; 51(5):315-9. PubMed ID: 20534951
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of measuring the blood concentration of itraconazole oral solution in the field of hematology.
Shimoeda S; Nakagawa S; Kobayashi H; Yamato S; Kawano K; Ohta S
Biol Pharm Bull; 2010; 33(11):1861-6. PubMed ID: 21048312
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole for invasive fungal infection with pediatric malignancies.
Kobayashi R; Suzuki D; Yasuda K; Kobayashi K
Pediatr Int; 2010 Oct; 52(5):707-10. PubMed ID: 20337979
[TBL] [Abstract][Full Text] [Related]
6. [Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
Kawano I; Matsumoto K; Jiromaru T; Jinnochi F; Semba Y; Sugio T; Sakamoto K; Saito N; Yoshida S; Henzan H; Takase K; Morita K; Eto T
Rinsho Ketsueki; 2016; 57(12):2475-2480. PubMed ID: 28090013
[TBL] [Abstract][Full Text] [Related]
7. [Effect of prophylaxis against myocosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole].
Toubai T; Tanaka J; Fujisawa F; Kondo Y; Imamura M; Ota S; Hashino S; Yonetumi M; Chiba K; Kondo T; Toyoshima N; Asaka M
Jpn J Antibiot; 2003 Feb; 56(1):61-5. PubMed ID: 12723400
[TBL] [Abstract][Full Text] [Related]
8. [Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
Toubai T; Tanaka J; Ota S; Kato N; Umehara S; Kahata K; Toyoshima N; Asaka M; Imamura M
Jpn J Antibiot; 2005 Dec; 58(6):507-17. PubMed ID: 16521343
[TBL] [Abstract][Full Text] [Related]
9. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
[TBL] [Abstract][Full Text] [Related]
10. [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
Ota S; Wada A; Kosugi M; Matsuoka S; Asanuma S; Fujii S; Noguchi S; Nakata M; Imai K; Hirano T; Kobayashi N; Ogasawara M; Kiyama Y; Kasai M
Rinsho Ketsueki; 2010 Jan; 51(1):63-8. PubMed ID: 20134142
[TBL] [Abstract][Full Text] [Related]
11. Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
Marumo A; Miyawaki S; Dan N; Ishiyama K
Ther Drug Monit; 2017 Jun; 39(3):229-234. PubMed ID: 28445212
[TBL] [Abstract][Full Text] [Related]
12. Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
Mochizuki M; Murase S; Takahashi K; Shimada S; Kume H; Iizuka T; Fukuda M
Nihon Ishinkin Gakkai Zasshi; 2000; 41(1):33-9. PubMed ID: 10660641
[TBL] [Abstract][Full Text] [Related]
13. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
14. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
Nakamura Y; Matsumoto K; Sato A; Morita K
J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?
Iriyama N; Matsukawa Y; Miura K; Inomata H; Hirabayashi Y; Hatta Y; Horikoshi A; Takeuchi J
J Infect Chemother; 2011 Dec; 17(6):744-9. PubMed ID: 21523410
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
17. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
20. [Change in serum concentration of itraconazole according to its dosage form].
Chineno T
Jpn J Antibiot; 2008 Apr; 61(2):92-4. PubMed ID: 18709729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
